Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology. Its lead product candidate is taletrectinib, an ROS1 inhibitor for the ...

KCET 2026 Syllabus: The Karnataka Examinations Authority have released the KCET syllabus 2026 across all the subjects on its ...

Bloomington, Ind. — To celebrate the historic win against Ohio State, The Indiana Daily Student (IDS) is proud to announce the release of its 2025 Big Ten Championship edition commemorative ...

IntraBio Inc. today announced that the European Commission granted marketing authorization to AQNEURSA(levacetylleucine) for the treatment of neurological manifestations of Niemann-Pick Type C (NPC) ...